Перегляд за автором "Zavyalova, M.V."

Сортувати за: Порядок: Результатів:

  • Gerashchenko, T.S.; Denisov, E.V.; Novikov, N.M.; Tashireva, L.A.; Kaigorodova, E.V.; Savelieva, O.E.; Zavyalova, M.V.; Cherdyntseva, N.V.; Perelmuter, V.M. (Experimental Oncology, 2018)
    Aim: To identify gene expression profiles involved in drug resistance of different morphological structures (tubular, alveolar, solid, trabecular, and discrete) presented in breast cancer. Material and Methods: Ten patients ...
  • Gerashchenko, T.S.; Denisov, E.V.; Novikov, N.M.; Tashireva, L.A.; Kaigorodova, E.V.; Savelieva, O.E.; Zavyalova, M.V.; Cherdyntseva, N.V.; Perelmuter, V.M. (Experimental Oncology, 2018)
    Aim: To identify gene expression profiles involved in drug resistance of different morphological structures (tubular, alveolar, solid, trabecular, and discrete) presented in breast cancer. Material and Methods: Ten patients ...
  • Tashireva, L.A.; Denisov, E.V.; Savelieva, O.E.; Geraschenko, T.S.; Zavyalova, M.V.; Perelmuter, V.M. (Вiopolymers and Cell, 2015)
    Aim. To investigate the expression of the genes TGFB1, TNF, CSF1, CSF2, VEGFA and HIF1A in the patients with invasive breast carcinoma of no special type considering the intratumoral morphological heterogeneity. Methods. ...
  • Vtorushin, S.V.; Khristenko, K.Y.; Zavyalova, M.V.; Perelmuter, V.M.; Litviakov, N.V.; Denisov, E.V.; Dulesova, A.Y.; Cherdyntseva, N.V. (Experimental Oncology, 2014)
    Multi-drug resistance (MDR) is a condition when there is broad cross-resistance of cells to various agents which are different in structure and effect. Modern perceptions on mechanisms of MDR development in malignant tumors ...